None listed
Conditions
Interventions
Drug : The control group does not administer investigational drugs, and the Tegoprazan group administers Tegoprazan 50mg for a total of 8 weeks
Sponsors
Kangdong Sacred Heart Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Those who are over 20 years of age as of the date of obtaining written consent with heartburn or gastroesophageal reflux symptoms 2) Those who have agreed to participate in the study and completed the questionnaire for this study 3) A regular worker who works for an average of 8 hours a day and 40 hours a week and is employed with a salary of at least the minimum wage (9,620 won per hour*) * The standard of KRW 9,620 per hour under the 2023 Minimum Wage Act (can be changed depending on the application of the law based on the date of obtaining written consent)
Exclusion criteria
Exclusion criteria: 1) Those who did not complete the questionnaire 2) Patients with malignancy or warning symptoms indicating malignancy (weight loss, anemia, melena, persistent vomiting, etc.) 3) a neurosis or psychotic patient undergoing psychiatric treatment 4) a dementia patient 5) Those who with chronic diseases other than high blood pressure and diabetes(asthma, chronic obstructive pulmonary disease, chronic hepatitis, cirrhosis, angina, myocardial infarction, heart failure, chronic renal failure, etc.) 6) Patient who took gastric acid inhibitors(proton pump inhibitors, H2 receptor antagonists, potassium competitive gastric acid inhibitors) within 2 weeks prior to visit 2 7) Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Absenteeism | — |
Secondary
| Measure | Time frame |
|---|---|
| Presenteeism;SF-36 score;Economic burden | — |
Countries
Korea, Republic of
Contacts
Public ContactSang Hee Kim
Kangdong Sacred Heart Hospital
Outcome results
None listed